Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind multicenter trial of tapentadol hydrochloride injection for postoperative analgesia after orthopedic surgery
CTR20250671Phase 3Active
- Sponsor
- Huatai Chenguang Pharmaceutical
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tapentadol in postoperative pain, sponsored by Huatai Chenguang Pharmaceutical. Started Jun 2026; status: active.
02
Drugs
tapentadol
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20250671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250671.